Chronomodulated chemotherapy and irradiation: an idea whose time has come?

REFERENCES

• Bjarnason G.A., Jordan R. Circadian Variation of Cell Proliferation and Cell Cycle Protein Expression in Man: Clinical Implications. Prog. Cell Cycle Res. 2000; 4: 193–206
   PubMedGoogle Scholar
• Potten C.S., Hendry J.H. Structure, Function and Proliferative Organization of Mammalian gut. Radiation and Gut. Elsevier, Amsterdam 1995; 18
   Google Scholar
• Scheving L.E., F. R.J., Tsai T.H., Scheving L.A. Experimental Background for Cancer Chronotherapy. Circadian Cancer Ther. 1994; 19–40
   Google Scholar
• Scheving L.E., Burns E.R., Pauly J.E., Tsai T.H. Circadian Variation and Cell Division of the Mouse Alimentary Tract, Bone Marrow, and Corneal Epithelium. Anat. Rec. 1983; 191: 479
   Google Scholar
• Potten C.S., Kellett M., Rew D.A., Roberts S.A. Proliferation in Human Gastrointestinal Epithelium Using Bromodeoxyuridine In Vivo: Data for Different Sites, Proximity to a Tumor, and Polyposis Coli. Gut 1992; 33: 524–529
   PubMed Web of Science ®Google Scholar
• Becciolini A., Balzi M., Fabbrica D., Potten C.S. Cell Kinetics in Rat Small Intestine After Exposure to 3 Gy of γ-Rays at Different Times of the Day. Int. J. Radiat. Biol. 1996; 70(3)281–288
   PubMed Web of Science ®Google Scholar
• Ruifrok A.C., Weil M.M., Thames H.D., Mason K.A. Diurnal Variations in the Expression of Radiation-Induced Apoptosis. Radiat. Res. 1998; 149(4)360–365
   PubMed Web of Science ®Google Scholar
• Becciolini A., Balzi M., Potten C.S. Radiation Effects on Proliferation and Differentiation in the Rat Small Intestine. Radiation and Gut. Elsevier, Amsterdam 1997; 94
   Google Scholar
• Warnakulasuriya K.A., MacDonald D.G. Diurnal Variation in Labelling Index in Human Buccal Epithelium. Arch. Oral Biol. 1993; 38(12)1107–1111
   PubMedGoogle Scholar
• Bjarnason G.A., Jordan R.C., Sothern R.B. Circadian Variation in the Expression of Cell-Cycle Proteins in Human Oral Epithelium. Am. J. Pathol. 1999; 154(2)613–622
   PubMed Web of Science ®Google Scholar
• Buchi K.N., M. J.G., Hrushevsky W.J.M., Sothern R.B., Rubin N.H. Circadian Rhythm of Cellular Proliferation in the Human Rectal Mucosa. Gastroenterology 1991; 101: 410
   PubMed Web of Science ®Google Scholar
• Marra G., Anti M., Percesepe A., Armelao F., Ficarelli R., Coco C., Rinelli A., Vecchio F.M., D'Arcangelo E. Circadian Variations of Epithelial Cell Proliferation in Human Rectal Crypts. Gastroenterology 1994; 106(4)982–987
   PubMed Web of Science ®Google Scholar
• Smaaland R., L. O.D., Abrahamsen J.F. Circadian Cell Kinetics in Humans. Aspects Related to Cancer Chemotherapy. In Vivo 1995; 9: 529–538
   PubMedGoogle Scholar
• Wilsbacher L.D., Takahashi J.S. Circadian Rhythms: Molecular Basis of the Clock. Curr. Opin. Genet. Dev. 1998; 8: 595–602
   PubMed Web of Science ®Google Scholar
• Sehgal A., Ousley A., Yang Z., Chen Y., Schotland P. What Makes the Circadian Clock Tick: Genes That Keep Time?. Recent Prog. Horm. Res. 1999; 54: 61–84
   PubMedGoogle Scholar
• Barinaga M. Circadian Rhythms. Two Feedback Loops Run Mammalian Clock. Science 2000; 288(5468)943–944
   PubMedGoogle Scholar
• Zhang R. Pharmacologic Basis for Circadian Pharmacodynamics. Circadian Cancer Ther. 1994
   Google Scholar
• Bjarnason G.A., Hrushesky W.J.M. Preclinical Trials of Cancer Chronotherapy. Circadian Cancer Ther. 1994
   Google Scholar
• Peters G.J., V. D.J., Nadal J.C., Van Groeningen C.J., Lankelma J., Pinedo H.M. Diurnal Variation in the Therapeutic Efficacy of 5-Fluorouracil Against Murine Colon Cancer. In Vivo 1987; 1: 113
   PubMedGoogle Scholar
• Shakil A., Hirabayashi N., Toge T. Circadian Variation of 5-Fluorouracil and Cis-Platinum Toxicity in Mice. Hiroshima J. Med. Sci. 1993; 42(4)147–154, December, 1993 Jap mouse paper
   PubMedGoogle Scholar
• Burns E.R., B. S.S. Effect of Biological Time on the Determination of the LD50 of 5-fluorouracil in Mice. Pharmacology 1984; 28: 296
   PubMedGoogle Scholar
• Daher G.C., Harris B.E., Willard E.M., Diasio R.B. Biochemical Basis for Circadian-Dependent Metabolism of Fluoropyrimidines. Ann. NY Acad. Sci. 1991; 618: 350–361
   PubMed Web of Science ®Google Scholar
• Zhang R., L. Z., Liu T., Soong S.J., Diasio R.B. Relationship Between Circadian-Dependent Toxicity of 5-Fluorodeoxyuridine and Circadian Rhythms of Pyrimidine Enzymes;Possible Relevance to Fluoropyrimidine Chemotherapy. Cancer Res. 1993; 53: 2816
   PubMed Web of Science ®Google Scholar
• Milano G., Etienne M.C. Individualizing Therapy with 5-Fluorouracil Related to Dihydropyrimidine Dehydrogenase: Theory and Limits. Ther. Drug Monitor. 1996; 18(4)335–340
   PubMedGoogle Scholar
• Badran A.F. Persistence of Mitotic Circadian Rhythm of the Transplantable Mammary Carcinoma After 35 Generations: Its Bearing on the Success of Treatment. JNCI 1965; 35: 285
   PubMedGoogle Scholar
• Cornelissen G., Halberg F. The Chronobiologic Pilot Study with Special Reference to Cancer Research. Is Chronobiology or Rather Its Neglect Wasteful?. Cancer Management in Man. Detection, Diagnois, Surgery, Radiology, Chronobiology, Endocrine Therapy, A.L. Goldson. Kluwer Academic Publishers, Dordrecht, The Netherlands 1989; 103–133
   Google Scholar
• Bjarnason G.A., Hrushesky W.J.M. Cancer Chronotherapy. Circadian Cancer 1994
   Google Scholar
• Kirichenko A.V., Rich T.A. Radiation Enhancement by 9-Aminocamptothecin: the Effect of Fractionation and Timing of Administration. Int. J. Radiat. Oncol. Biol. Phys. 1999; 44(3)659–664
   PubMedGoogle Scholar
• Filipski E., L. F., Vardot N., Li X.M. Circadian Changes in Irinitecan Toxicity in Mice. Proc. AACR 1997; 38: 305
   Google Scholar
• Ohdo S., Makinosumi T., Ishizaki T., Yukawa E., Higuchi S., Nakano S., Ogawa N. Cell Cycle-Dependent Chronotoxicity of Irinotecan Hydrochloride. J. Pharmacol. Exp. Ther. 1997; 283: 1383–1388
   PubMed Web of Science ®Google Scholar
• Montembault S., Goldwasser F., Bresault-Bonnet C., Giacchetti S., Tigaud J.M., Metzger G., Jasmin C., Misset J.L., Levi F. A Pilot Study of CPT-11 Chronomodulated Delivery in Patients with Metastatic Colorectal Carcinoma. Proc., AACR 1998; 39
   Google Scholar
• Haus E., H. F., Loken M.K., Kim U.S. Circadian Rhythmometry of Mammalian Radiosensitivity. Space Radiation Biology, A. Tobias, P. Todd. Academic Press, New York 1973; 435–474
   Google Scholar
• Halberg F., H. J., Halberg E., Halberg F. Chronobiology, Radiobiology, and Steps Toward the Timing of Cancer Radiotherapy. Cancer Management in Man. Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy. Kluwer Academic Publishers, Dordrecht, The Netherlands 1989; 227–253
   Google Scholar
• Hirn-Stadler B., Rosas A. Influence of Circadian Rhythms on Radiosensitivity: Single and Fractionated Dose Studies in Mouse Skin. Int. J. Radiat. Biol. 1991; 59(1)185–193
   PubMed Web of Science ®Google Scholar
• Deka A.C., C. B., Gupta B.D., Balakrishnan C., Dutta T.K. Temperature Rhythm—An Index of Tumor Regression and Mucositis During the Radiation Treatment of Oral Cancers. Indian J. Cancer 1976; 13(1)44–50
   PubMedGoogle Scholar
• Bjarnason, G. Personal Communication, 4/2000.
   Google Scholar
• Herskovic A., Martz K., Al-Sarraf M., Leichman L., Brindle J., Vaitkevicius V., Cooper J., Byhardt R., Davis L., Emami B. Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus. N. Engl. J. Med. 1992; 326: 1593–1598
   PubMed Web of Science ®Google Scholar
• Poen J.C., Collins H.L., Niederhuber J.E., Oberhelman H.A., Vierra M.A., Bastidas A.J., Young H.S., Slosberg E.A., Jeffrey B.R., Longacre T.A., Fisher G.A., Goffinet D.R. Chemo-Radiotherapy for Localized Pancreatic Cancer: Increased Dose Intensity and Reduced Acute Toxicity with Concomitant Radiotherapy and Protracted Venous Infusion 5-Fluorouracil. Int. J. Radiat. Oncol. Biol. Phys. 1998; 40: 93–99
   PubMedGoogle Scholar
• Rich T.A. Infusional Chemoradiation for Operable Rectal Cancer: Post-, Pre-, or Nonoperative Management?. Oncology 1997; 11(3)295–300
   PubMedGoogle Scholar
• Rich T.A., Ajani J.A., Morrison W.H., Ota D., Levin B. Chemoradiation Therapy for Anal Cancer: Radiation Plus Continuous Infusion of 5-Fluorouracil with or without Cisplatin. Radiother. Oncol. 1993; 27: 209–215
   PubMed Web of Science ®Google Scholar
• Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E., Rotman M., Gershenson D.M., Mutch D.G. Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-aortic Radiation for High-Risk Cervical Cancer. New Engl. J. Med. 1999; 340(15)1137–1143
   PubMed Web of Science ®Google Scholar
• Rich T.A. Chemoradiation or Accelerated Fractionation: Basic Considerations. J. Infus. Chemother. 1992; 1: 2–8
   Google Scholar
• Levi F., Z. R., Vannetzel J-M., Perpoint B., Focan C., Faggiuolo R., Chollet P., Garufi C., Itzhaki M., Dogliotti L., Iacobelli S., Adam R., Kunstlinger F., Gastiaburu J., Bismuth H., Jasmin C., Misset J-L. Chronomodulated Versus Fixed-Infusion-Rate Delivery of Ambulatory Chemotherapy with Oxaliplatin, Fluorouracil, and Folinic Acid(Leucovorin) in Patients with Colorectal Cancer Metastases: A Randomized Multi-Institutional Trial. J. Natl Cancer Inst. 1994; 86(21)1608–1617
   PubMed Web of Science ®Google Scholar
• de W., Marsh R., C. N.-M., Vauthey J-N., Mendenhall W.M., Lauwers G.Y., Bewsher C., Copeland E.M. Preoperative Treatment of Patients with Locally Advanced Unresectable Rectal Adenocarcinoma Utilizing Continuous Chronobiologically Shaped 5-Fluorouracil Infusion and Radiation Therapy. Cancer 1996; 78: 217–225
   PubMedGoogle Scholar
• O'Connell M.J., M. J.A., Wieand H.S., et al. Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy After Curative Surgery. N. Engl. J. Med. 1994; 331: 502–507
   PubMed Web of Science ®Google Scholar
• Weinstein G.D., R. T.A., Shumate C.R., et al. Preoperative Infusional Chemoradiation and Surgery with or without an Electron Beam Intraoperative Boost for Advanced Primary Rectal Cancer. Int. J. Radiat. Oncol. Biol. Phys. 1995; 32: 197–204
   PubMedGoogle Scholar
• Khurshid A., E. J.P., Gramm T., Recht A. Pilot Study Using Concurrent Radiation Therapy and Continuous 5-FU Infusion Given in a Circadian Manner. Proc. ASCO 1997; A1042
   Google Scholar
• Penberthy D.R., Rich T.A., Shelton C.S., Adams R., Minasi J.S., Jones R.S. A Pilot Study of Chronomodulated Infusional 5-FU Chemoradiation for Pancreatic Cancer. Ann. Oncol. 2001; 12: 681–684
   PubMed Web of Science ®Google Scholar
• Bjarnason, G.; K., I.; Doyle, N.; MacDonald, M.; Sone, M. Phase I Study of 5-Fluorouracil and Leucovorin by 14-Day Continuous Infusion Chronotherapy in Patients with Metastatic Adenocarcinoma. Proceedings of Fifth International Conference of Chronopharmacology, Amelia Island, FL, 1992.
   Google Scholar
• McMasters K.M., Tuttle T.M., Leach S.D., Rich T.A., Cleary K.R., Evans D.B., Curley S. A: Neoadjuvant Chemoradiation for Extrahepatic Cholangiocarcinoma. Am. J. Surg. 1997; 174: 605–609
   PubMed Web of Science ®Google Scholar